The tariff classification of Methocarbamol Tablets USP (500mg & 750mg); Zonisamide Capsules (25mg, 50mg and 100mg); and Pravastatin Sodium Tablets (10mg, 20mg, 40mg and 80mg) from India
Reasoning
The tariff classification of Methocarbamol Tablets USP (500mg & 750mg); Zonisamide Capsules (25mg, 50mg and 100mg); and Pravastatin Sodium Tablets (10mg, 20mg, 40mg and 80mg) from India
Cite this ruling
CBP Ruling M84348 (3004909140): The tariff classification of Methocarbamol Tablets USP (500mg & 750mg); Zonisamide Capsules (25mg, 50mg and 100mg); and Pravastatin Sodium Tablets (10mg, 20mg, 40mg and 80mg) from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of a Large Road Hazard Kit
The tariff classification and country of origin marking of SinuCleanse®, under the North American Free Trade Agreement (NAFTA); Article 509
The tariff classification of Carbidopa/Levodopa Tablets and Methocarbamol Tablets from India
The tariff classification of Antara® (fenofibrate) capsules from France
The tariff classification of Lisinopril Tablets and Lisinopril/Hydrochlorothiazide Tablets from India